Cited by 548Tuberculosis Research and EpidemiologyImmune responses and vaccinationsInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Metformin as adjunct antituberculosis therapy

Singhal, Amit, Jie, Liu, Kumar, Pavanish, Hong, Gan Suay, Leow, Melvin Khee-Shing, Paleja, Bhairav, Tsenova, Liana, Kurepina, Natalia, Chen, Jinmiao, Zolezzi, Francesca, Kreiswirth, Barry, Poidinger, Michael, Chee, Cynthia, Kaplan, Gilla, Wang, Yee Tang, De Libero, Gennaro·2014·Science Translational Medicine

DOI 10.1126/scitranslmed.3009885

Open this paper in CoChat — free account

Abstract

The global burden of tuberculosis (TB) morbidity and mortality remains immense. A potential new approach to TB therapy is to augment protective host immune responses. We report that the antidiabetic drug metformin (MET) reduces the intracellular growth of Mycobacterium tuberculosis (Mtb) in an AMPK (adenosine monophosphate-activated protein kinase)-dependent manner. MET controls the growth of drug-resistant Mtb strains, increases production of mitochondrial reactive oxygen species, and facilitates phagosome-lysosome fusion. In Mtb-infected mice, use of MET ameliorated lung pathology, reduced chronic inflammation, and enhanced the specific immune response and the efficacy of conventional TB drugs. Moreover, in two separate human cohorts, MET treatment was associated with improved control of Mtb infection and decreased disease severity. Collectively, these data indicate that MET is a promising candidate host-adjunctive therapy for improving the effective treatment of TB.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3009885

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,328
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Mihaylova, M. M., & Shaw, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2329 · Cited by 2,923
Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages
Gutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., & Deretic, V. (2004) · Cell · doi:10.1016/j.cell.2004.11.038 · Cited by 2,252
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Tlr signalling augments macrophage bactericidal activity through mitochondrial ros
West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., & Ghosh, S. (2011) · Nature · doi:10.1038/nature09973 · Cited by 1,659

Show all 49 references

Sorted by citations

Items 401–500 of 548

Metabolic reprogramming of immune cells in the battle against intracellular bacterial chronic infections: novel mechanisms and breakthroughs
Jiang, R., Liu, X., Xing, F., Fu, Y., & Zhengjun, Y. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11218-3 · Cited by 3
Host-directed insights into mycobacterial infections: Toward targeted immunomodulation
Menon, A. M., Abhinand, K., Thomas, S. S., Salini, S., Edison, L. K., Mohanan, P. C. P., Arun, K. B., Babu, P., Kumar, G. B., Nair, B. G., et al. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108233 · Cited by 3
Effects of Hypoglycemic Agents on Pulmonary Diseases: A Comprehensive Narrative Review
Yang, Y., Wang, K., & CHEN, S. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s556790 · Cited by 4
Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions
García, J. P., Chung, C. J., Flowers, R. C., Evans, S. E., & Wu, B. G. (2026) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.12.018 · Cited by 3
Prospects of Inhalable Formulations of Conventionally Administered Repurposed Drugs for Adjunctive Treatment of Drug-Resistant Tuberculosis: Supporting Evidence from Clinical Trials and Cohort Studies
Ranjan, R., & Devireddy, V. S. R. (2024) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2024.0051 · Cited by 3
Thiazolidinediones and reduced risk of incident bacterial abscess in adults with type 2 diabetes: A population‐based cohort study
Wang, J., Dong, Y., Ko, W., Chang, C., Wu, L., Chuang, L., & Chen, P. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13461 · Cited by 3
When to Die Is the Question: Need and Manipulation of Cell Death by Mycobacterium
Mittal, E., Deore, S., Kumar, M., & Krishnasastry, M. V. (2020) · Current Molecular Biology Reports · doi:10.1007/s40610-020-00137-w · Cited by 3
Treatment of infection-induced vascular pathologies is protective against persistent rough morphotype Mycobacterium abscessus infection in zebrafish
Kam, J. Y., Wright, K., Britton, W. J., & Oehlers, S. H. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105590 · Cited by 3
Protective effect of metformin against tuberculosis in diabetic patients
Miraj, S. S., Unnikrishnan, M. K., & Vyas, N. (2016) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2016.05.004 · Cited by 3
Metformin Causes Hepato-renal Dysfunctions in Obese Male Rats
El-Naggar, S. A., Elwan, M., Basyouny, M. A. E., Elshennawy, E. O., & El-Said, K. S. (2021) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2021210188 · Cited by 3
Drug Repurposing for Tuberculosis
Cardoso, N. C., Oosthuizen, C. B., Peton, N., & Singh, V. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.101393 · Cited by 3
Metformin: A Leading HDT Candidate for TB
Singhal, A., & Kornfeld, H. (2020) · Springer eBooks · doi:10.1007/978-3-030-56905-1_7 · Cited by 3
Self-citation
Host directed therapies (HDTs) and immune response signatures: insights into a role for interleukin-32.
Maeurer, M. J., Rao, M., & Zumla, A. I. (2015) · PubMed Central · doi:10.3978/j.issn.2305-5839.2015.03.65 · Cited by 3
Enlisting the Host to Fight TB
Kornfeld, H., & Singhal, A. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.01.011 · Cited by 3
Self-citation
Genome-wide screen in Mycobacterium tuberculosis infected macrophages reveals innate regulation of antibacterial mediators by IRF2Preprint
Roberts, A. W., Cid, L. N. D., Garelis, N. E., & Cox, J. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.26.678671 · Cited by 3
From clinical phenotypes to genomic signatures: machine learning integration for precision tuberculosis treatment prediction
Li, L., Liu, H., Lei, Q., & Li, T. (2026) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2026.1787360 · Cited by 2
Targeting metabolism to combat anticancer and antibacterial drug resistance
Chung, C. H., Bhowmick, R., Badenoch, A. J., Arora, H. S., & Chandrasekaran, S. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.01.013 · Cited by 2
Metformin for Tuberculosis Infection
Novita, B. D., Muliono, A. C., & Erwin, F. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99794 · Cited by 2
Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism
Kim, J.-S., Kim, Y.-R., & Yang, C. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/paimmu2ed.2.2020.4 · Cited by 2
Effect and possible mechanisms of metformin as adjuvant therapy in the management of tuberculosis: A prospective study
Mishra, R., Krishan, S., Rai, P. K., Kapur, P., Khayyam, K. U., Azharuddin, M., Sharma, K., & Sharma, M. (2022) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2022.101106 · Cited by 2
Stratification of Nontuberculous Mycobacterial Disease Risk in Type 2 Diabetes Based on Metformin Use: a Population-Based Cohort Study in South Korea
Kim, H. H., Kim, S., Kim, M. A., Jung, C. H., Chong, Y. P., Shim, T. S., Kim, Y., & Jo, K. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01675-22 · Cited by 2
Risk factors for treatment failure in multidrug resistant tuberculosis in Tunisia: An analytic study
Tritar, F., Saad, S. B., Ferchichi, M., Mansour, A. B., Slim, A., Naffati, O., Bellali, H., Slim, L., & Daghfous, H. (2024) · La Tunisie Médicale · doi:10.62438/tunismed.v102i1.4521 · Cited by 2
Exploring necrosis-associated mitochondrial gene signatures: revealing their role in prognosis and immunotherapy of renal clear cell carcinoma
Wang, Z., Zheng, F., Wei, S., Li, S., Xiong, S., Zhang, L., Wan, L., Xu, S., Deng, J., & Liu, X. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01426-9 · Cited by 2
Metformin in COVID-19: a magical role beyond the hyperglycemia
Chaubey, G. K., Dilawari, R., Modanwal, R., Talukdar, S., Dhiman, A., & Raje, M. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00055 · Cited by 2
Host-Directed Omics Approaches to Tackle Antimicrobial Resistance
Rastogi, S., & Chandra, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-65986-7_10 · Cited by 2
Allium Sativum Manipulated AgNP‐Metformin Conjugated Nanostructure: Therapeutic Strategy for Enhanced Antibacterial Action against Multidrug‐Resistant Staphylococcus aureus and Escherichia coli
Mahapatra, S. D., Bhattacharya, D., Das, S., Mandal, S., Sen, N., Sepay, N., Bhattacharya, S. K., Ghosh, A., & Sinha, C. (2025) · ChemistrySelect · doi:10.1002/slct.202501282 · Cited by 2
In utero exposure to anti-Caspr2 antibody disrupts parvalbumin interneuron function in the hippocampus
Bagnall-Moreau, C., Strohl, J. J., Spielman, B. P., Cruz, C., Huerta, P. T., & Brimberg, L. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106192 · Cited by 2
Cellular and Molecular Mechanisms of Repurposed Antidiabetic Drug as an Adjunctive Treatment for Tuberculosis
Gautam, R. K., Mishra, R., Sharma, K., & Sharma, M. (2021) · Springer eBooks · doi:10.1007/978-981-33-6827-9_15 · Cited by 2
More than merely drug resistance
Chen, Y., & Javid, B. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0250-3 · Cited by 2
Recent advancement and future perspective for the treatment of multidrug-resistant tuberculosis
Shariff, N. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00014-x · Cited by 2
Metformin use and post-exposure incident tuberculosis: a nationwide tuberculosis-contact cohort study in Taiwan
Pan, S., Feng, J., Yen, Y., Chuang, F., Shen, H., Su, V. Y., Chuang, P., Chan, Y., & Su, W. (2020) · ERJ Open Research · doi:10.1183/23120541.00050-2020 · Cited by 2
Sirtuin Deacetylases: Linking Mycobacterial Infection and Host Metabolism
Smulan, L. J., Kornfeld, H., & Singhal, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-56905-1_2 · Cited by 2
Self-citation
[Hypertensive crisis: problems of diagnostics and paradigm of the treatment].
Fursov, A. N., Potekhin, N. P., Chernov, S. A., Vereshchagina, A. V., Захарова, Е. Г., & Nn, O. (2012) · PubMed · Cited by 2
Challenges and Advances in TB Drug Discovery
Khare, G., Nangpal, P., & Tyagi, A. K. (2019) · Springer eBooks · doi:10.1007/978-981-32-9413-4_25 · Cited by 2
Disulfiram inhibits M. tuberculosis growth by altering methionine pool, redox status and host-immune responsePreprint
Chaudhary, D., Marzuki, M., Lee, A., Bouzeyen, R., Singh, A., Gosain, T. P., Kidwai, S., Grady, C. A., Tsotetsi, K., Chawla, K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.01.277368 · Cited by 2
Self-citation
Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-directed TherapiesPreprint
Brown, R. E. E., & Hunter, R. L. (2021) · Preprints.org · doi:10.20944/preprints202107.0404.v2 · Cited by 2
Discovery of anti-infective compounds against Mycobacterium marinum after biotransformation of simple natural stilbene scaffolds by a fungal secretomePreprint
Nitschke, J., Huber, R., Vossio, S., Moreau, D., Marcourt, L., Gindro, K., Queiroz, E. F., Soldati, T., & Hanna, N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.18.590143 · Cited by 2
Genome-wide screen of Mycobacterium tuberculosis- infected macrophages identified the GID/CTLH complex as a determinant of intracellular bacterial growthPreprint
Simwela, N. V., Johnston, L., Bitar, P. P., Jaecklein, E., Altier, C., Sassetti, C. M., & Russell, D. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.06.592714 · Cited by 2
Butyrate preserves entorhinal-hippocampal spatial coding and blood brain barrier integrity in mice with depleted gut microbiomePreprint
Glynn, J. M., Strohl, J. J., Bagnall-Moreau, C., Carrión, J., & Huerta, P. T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.24.666609 · Cited by 2
Host-Directed Therapies for TuberculosisPreprint
Oehlers, S. H., Agarwal, S., & Singhal, A. (2026) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041823 · Cited by 3
Self-citation
Tuberculosis
Rustomjee, R. (2021) · doi:10.1093/med/9780198816805.003.0072 · Cited by 1
Collaboration Models for Repurposing
Bloom, B. E. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839163401-00074 · Cited by 1
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
Painter, H., Larsen, S. E., Williams, B. D., Abdelaal, H. F. M., Baldwin, S. L., Fletcher, H. A., Fiore-Gartland, A. J., & Coler, R. N. (2024) · mSphere · doi:10.1128/msphere.00864-24 · Cited by 1
Lessons from cross-pathogen studies: understanding the metabolic rewiring of macrophages upon infection
Pérez-Toledo, M., & Llibre, A. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1584777 · Cited by 1
Reimagining Tuberculosis Treatment: The Promise of Immunotherapy and Drug Repurposing
Shinde, S., Rathod, S., & Chitlange, S. S. (2025) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/0118756921381395250614152438 · Cited by 1
Deciphering macrophage dynamics and immune evasion strategies by the intracellular bacteria
Munir, F., He, B., Shakoor, A., Liu, J., & Ma, W. (2025) · Immunologic Research · doi:10.1007/s12026-025-09696-5 · Cited by 1
Host-pathogen interactions in tuberculosis: from immunological mechanisms to translational applications
Chai, Q., Lei, Z., & Liu, C. H. (2026) · Cell Insight · doi:10.1016/j.cellin.2026.100352 · Cited by 1
p38 MAPK and MDT-15 mediate SKN-1-dependent metformin-induced protection against mitis group streptococci in Caenorhabditis elegans
Hatem, A. A., Balasubramaniam, B., Villhauer, A. L., Naji, A. K., & van der Hoeven, R. (2026) · GeroScience · doi:10.1007/s11357-026-02405-6 · Cited by 1
The effect of metformin on the pharmacokinetics of rifampicin, isoniazid, and pyrazinamide in adults with tuberculosis
Rossouw, M. J., Wallis, R., Kornfeld, H., Singhal, A., Maartens, G., Wiesner, L., Denti, P., & Wasmann, R. E. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00748-26 · Cited by 1
Self-citation
Cracking bacterial persisters: from molecular mechanisms and host adaptation to novel methodologies and countermeasures
Zhang, F., Yang, L., Wang, X., Lu, B., & Cao, B. (2026) · 中国科学通报：英文版 · doi:10.1016/j.scib.2026.08.028 · Cited by 1
Autophagy in tuberculosis: advances, translational gaps, and the promise of host-directed therapies
Challa, M., Jessy Padma, B., & Shanmugam, S. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1896798 · Cited by 1
A new method for multi-sample high-dimensional covariance matrices test based on permutation
Yu, W. (2020) · Communication in Statistics- Theory and Methods · doi:10.1080/03610926.2020.1815782 · Cited by 1
Drug Repurposing in Biomedical Research: Benefits and Challenges
Sharma, A., & Kaur, J. (2022) · Springer eBooks · doi:10.1007/978-981-16-9232-1_3 · Cited by 1
Small molecules targeting endolysosomal acidification and signaling in sepsis and severe SARS-CoV-2 infection/COVID-19
Blaess, M. F., Sommerfeld, O., Csük, R., & Deigner, H. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00063 · Cited by 1
Repurposing of Metformin for the prevention and treatment of Tuberculosis
Vyas, N., Punchathidil, R., Swain, A., Shakeer, I., Reddy, B. S., Manu, M. K., & Miraj, S. S. (2022) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902022e20422 · Cited by 1
Research progress of pyrazinamide in the treatment of drug-resistant tuberculosis
Yunchang Yang, F. L. (2025) · Academic Journal of Medicine & Health Sciences · doi:10.25236/ajmhs.2025.060204
Metformin Associated Interleukin-10 Affected Insulin Sensitivity and Anti-Tuberculosis Result in Type 2 Diabetes with Tuberculosis Coinfection: A Case Report
Novita, B. D. (2018) · Journal of Clinical Respiratory Diseases and Care · doi:10.4172/2472-1247.1000136 · Cited by 1
Modulation of Inflammation to Control Tuberculosis Disease
Hwang, S., & Actor, J. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813832-8.00007-8 · Cited by 2
Measuring the Impact of Online Education on Academic Performance Amid COVID-19 with the Moderating Effect of Instructor
Fahim, S., Zaidi, S. B. I., Rehman, A. U., Hussain, S., Khan, U. A., & Hasan, A. H. (2021) · International Journal of Embedded Systems · doi:10.31901/24566322.2021/33.1-3.1170 · Cited by 1
What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis
Bothamley, G. H. (2018) · European Respiratory Society eBooks · doi:10.1183/2312508x.10026118 · Cited by 1
Metformin: A Small Molecule with Multi-Targets and Diverse Therapeutic Applications
Badria, A. F., Ali, A. R., Elbermawi, A., Amen, Y. M., & Badria, A. F. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108884 · Cited by 1
Fatty acid oxidation impairs macrophage effector functions that control Mycobacterium tuberculosisPreprint
Chandra, P., He, L. N., Zimmerman, M. D., Yang, G., Köster, S., Ouimet, M. I., Wang, H., Moore, K. J., Dartois, V. A., Schilling, J. D., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/799619 · Cited by 1
Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidityPreprint
Eckold, C., van Doorn, C. L. R., Ruslami, R., Ronacher, K., Riza, A., van Veen, S., Lee, J., Kumar, V., Kerry-Barnard, S. R., Malherbe, S. T., et al. (2022) · medRxiv · doi:10.1101/2022.02.07.22269422 · Cited by 1
Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Hostdirected TherapiesPreprint
Brown, R. E., & Hunter, R. L. (2021) · Preprints.org · doi:10.20944/preprints202107.0404.v1 · Cited by 1
Impaired fatty acid import or catabolism in macrophages restricts intracellular growth of Mycobacterium tuberculosisPreprint
Simwela, N. V., Jaecklein, E., Sassetti, C. M., & Russell, D. G. (2024) · eLife · doi:10.7554/elife.102980.1 · Cited by 1
Use of lung microbiota strains to shape local immunity at steady state and during Mycobacterium tuberculosis infection in the mouse model
Bernard, L. (2020) · theses.fr (ABES) · doi:10.70675/589a776dz18d9z4813z9d6fzd73632aa4df7 · Cited by 1
ECOTURISMO – UMA PROPOSTA DE IMPLANTAÇÃO NA RESERVA PARTICULAR DE PATRIMÔNIO NATURAL FAZENDA PANTANAL, CODÓ- MA
Carvalho, R. R., Silva, M. S., Moreira, E. R. D. M., de Morais, F. M., Oliveira, M. R. A., & de Sousa, A. M. B. (2021) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001195
Estado del arte: metformina, cáncer y leucemia
Ramos-Peñafiel, C. O., Santoyo-Sánchez, A., Olarte-Carrillo, I., Queipo-García, G. E., Garfias, Y., & Martínez‐Tovar, A. (2015) · Revista de Hematología
State of the art: Metformin, cancer and leukemia
Ramos-Peñafiel, C. O., Santoyo-Sánchez, A., Olarte-Carrillo, I., Queipo-García, G. E., Garfias-Becerra, R. Y., & Martínez‐Tovar, A. (2015) · Revista de Hematología
Metformina: un arma noble para tiempos más civilizados
Ramos-Peñafiel, C. O., Santoyo-Sánchez, A., Olarte-Carrillo, I., Queipo-García, G. E., Garfias, Y., & Martínez‐Tovar, A. (2015) · Medicina Interna de México
Chemotherapy for Urogenital Tuberculosis
Kulchavenya, E. (2016) · Springer eBooks · doi:10.1007/978-3-319-28290-9_4
Metformin as a Preventative Therapy for Tuberculosis in Diabetic Patients
Magh, A., Sanso, L. M., & Zappetti, D. (2018) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000256
Novel Antimycobacterial Drugs and Host-Directed Therapies for Tuberculosis
Teskey, G., Cato, C., Hernandez, J., Kaur, P., Koury, J., Lucero, M., Tran, A., & Venketaraman, V. (2018) · Springer eBooks · doi:10.1007/978-3-319-97367-8_5
Tissue Location Drives the Metabolic Re-Profiling of Macrophages
Bouchery, T., Coakley, G., & Harris, N. L. (2020) · Immunometabolism · doi:10.20900/immunometab20200007
The role of infrared thermography (IRT) and magnetic resonance imaging (MRI) in brown fat evaluation and their application to study the effect of thyroid status on brown fat activity and white fat partitioning
Leow, M. K. S. (2019) · doi:10.32657/10356/137045
Self-citation
Medicamentos versátiles: buscando balas mágicas
Yamazaki‐Nakashimada, M. A., Rivas‐Larrauri, F., & Rosales-Hernandez, L.-A. (2020) · Revista Latinoamericana de Infectología Pediátrica · doi:10.35366/92384
The Mammalian Target of Rapamycin Complex 1 (mTORC1): An Ally of M. tuberculosis in Host Cells
Bruiners, N., Guerrini, V., & Gennaro, M. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-56905-1_3
Introduction: An Overview of Host-Directed Therapies for Tuberculosis
Frank, D. J., & Mahon, R. N. (2020) · Springer eBooks · doi:10.1007/978-3-030-56905-1_1
Metformin – nichtglykämische Wirkungen
Joost, H. (2021) · Der Diabetologe · doi:10.1007/s11428-020-00711-x
Metformin Role in Diabetic Patients with Tuberculosis: a Review
Wibisono, E. A. (2021) · Journal Of Tropical Pharmacy And Chemistry · doi:10.25026/jtpc.v5i3.275
Metformin – nichtglykämische Wirkungen
Joost, H. (2021) · Der Kardiologe · doi:10.1007/s12181-021-00497-2
The role of neutrophils in mycobacterial infection in zebrafish
Szkuta, P. T. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
ESTUDO DE POLIMORFISMOS NO GENE RECEPTOR DA VITAMINA D EM PACIENTES COM A DOENÇA DE ALZHEIMER
do Nascimento, H. V. A., Costa, A. D. S., Maia, M. D. M. D., da Silva, P. D. L., Prazeres, L. P. D. S., & de Souza, P. R. E. (2021) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001186
RECENT ADVANCES AND APPLICATIONS OF THE BIOPOLYMER LEVAN: ANOVERVIEW
de Siqueira, E. C. (2021) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001199
SÉRIE DE WILLIAMS ADAPTADA ASSOCIADA AO TREINAMENTO RESISTIDO: ANÁLISE DO QUADRO DA DOR LOMBAR EM UMA PACIENTE IDOSA
Cardoso, C. D. N. D., da Silva, J., Tenório, A. V. L., Cardoso, D. D. C., Azevedo, E. E. D. P., Amaral, E. E. M., da Gama, F. C., Brotas, F. R., Duarte, K. C., & de Sousa, E. C. (2021) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001191
APÊNDICE VERMIFORME E SUAS FUNÇÕES: MUITO ALÉM DE UM ÓRGÃO VESTIGIAL
Silva, T. F. P., Lobato, D. L., Melo, G. H. R., Aquino, I. P. D., Monteiro, L. N., Ribeiro, L. A. C., Godinho, M. C., Martins, M. G. S., Faria, S. H., & Santos, V. H. N. (2021) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001197
ESTIMATED GLOMERULAR FILTRATION RATE (EGFR) IN ELDERLY: A COMPARISON BETWEEN THE CKD-EPICREATININE AND BISCREATININE EQUATIONS
de Carvalho, V. M., Toledo, A. D. O., Toledo, A. C. O., Maciel, M. A. S., de Paula, J. P., & Borato, D. C. K. (2021) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001187
EVALUATION OF DRUG INTERACTIONS AND THEIR IMPACT ON VIROLOGICAL FAILURE OF PEOPLE LIVING WITH HIV/AIDS OVER 50 YEARS OF AGE
Favaleça, M. F., Gaggini, M. C. R., de Oliveira, W. L., & Boer, N. C. P. (2021) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001198
A INFLUÊNCIA DO SONO NA QUALIDADE DE VIDA E NO DESEMPENHO UNIVERSITÁRIO DE DISCENTES DO CURSO DE MEDICINA
Guimarães, V. L., Vaz, I. C. O. G., Ristov, I. R., Montella, F. C., de Araújo, G. S., & Cardoso, H. C. (2021) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001196
Antitubercular Agents
Aldrich, C. C., Wallis, R. S., Remmel, R. P., Hegde, P. V., & Stallings, C. L. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc298
Glycemic Control and the Risk of Tuberculosis: A Population-based Cohort StudyPreprint
Li, C., Hong, X., Ding, S., Kong, W., Ding, X., Zhu, L., Lu, W., Liu, Q., & Lü, P. (2020) · doi:10.21203/rs.3.rs-41181/v1
The Cumulative Dose-Dependent Effects of Metformin on the Development of Tuberculosis in Patients Newly Diagnosed with Type 2 Diabetes MellitusPreprint
Heo, E., Kim, E., Jang, E. J., & Lee, C. (2021) · Research Square · doi:10.21203/rs.3.rs-620529/v1
EFEITOS DA METFORMINA NO PERFIL INFLAMATÓRIO EM PACIENTES COM TUBERCULOSE E DIABETES TIPO 2
Oliveira, T. A. M. D. A., Gutiérrez, M. B. A., Kumar, N. P., Babu, S., Viswanathan, V., Fukutani, K. F., Kornfeld, H., & Andrade, B. B. (2021) · Brazilian Journals Editora eBooks · doi:10.35587/brj.ed.0001188
Immuno-modulatory drugs: A rapid way to combat the tuberculosis
Khan, Z., Ualiyeva, D., Ahmad, U., & Yusuf, B. (2022) · Medicine in Omics · doi:10.1016/j.meomic.2022.100016
Comorbilidades y Tuberculosis: Diabetes, Depresión y Enfermedad Renal Crónica
Gil, C. U. (2019) · Diagnóstico · doi:10.33734/diagnostico.v57i4.52
EFFECT OF METFORMIN ON THE EFFICIENCY OF ANTI-TUBERCULOSIS CHEMOTHERAPY
Malyugin, D. A., Shefer, A. A., & Nikolaev, V. A. (2023) · Научное обозрение Медицинские науки (Scientific Review Medical Sciences) · doi:10.17513/srms.1313
A wonder drug? New discoveries potentiate new therapeutic potentials of metformin
Matz, A., & Zhou, B. (2023) · Obesity Medicine · doi:10.1016/j.obmed.2023.100514
Use of the zebrafish model for target identification for host-directed therapies against tuberculosis
Larsson, S. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/180359
Interesting Metformin-based Derivatives with Versatile Pharmacology
Sahu, R., & Shah, K. (2025) · Current Organic Chemistry · doi:10.2174/0113852728361956241220051749
Impaired fatty acid import or catabolism in macrophages restricts intracellular growth of Mycobacterium tuberculosisPreprint
Simwela, N. V., Jaecklein, E., Sassetti, C. M., & Russell, D. G. (2025) · eLife · doi:10.7554/elife.102980.2

Authors: Singhal, A., Jie, L., Kumar, P., Hong, G. S., Leow, M. K.-S., Paleja, B., Tsenova, L., Kurepina, N., Chen, J., Zolezzi, F., Kreiswirth, B., Poidinger, M., Chee, C., Kaplan, G., Wang, Y. T., & De Libero, G.
Affiliations: Agency for Science, Technology and Research (SG)
Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.
Tan Tock Seng Hospital (SG)
Rutgers, The State University of New Jersey (US)
Corresponding author: Singhal, Amit
Kumar, Pavanish
ORCID: Singhal, Amit
Kumar, Pavanish
Leow, Melvin Khee-Shing
Paleja, Bhairav
Chen, Jinmiao
Zolezzi, Francesca
Kreiswirth, Barry
Poidinger, Michael
Chee, Cynthia
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2014-11-19
Volume: 6
Issue: 263
Pages: 263ra159-263ra159
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.3009885
OpenAlex: W2105296171
Cited by: 547
References: 49
Citations by year: 2026: 39 · 2025: 44 · 2024: 44 · 2023: 35 · 2022: 51 · 2021: 64 · 2020: 71 · 2019: 53 · 2018: 51 · 2017: 33 · 2016: 35 · 2015: 24 · 2014: 2
FWCI: 22.03
Type: journal article
Language: en
Open access: closed
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
National University of Singapore (submittedVersion)
edoc (University of Basel) (submittedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: metformin, tuberculosis, Mycobacterium tuberculosis, AMPK, host-directed therapy, drug-resistant tuberculosis, reactive oxygen species, phagosome-lysosome fusion, host immune response, chronic inflammation
MeSH terms: Humans, Metformin, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Tuberculosis, Reactive Oxygen Species

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metformin as adjunct antituberculosis therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks